Tezacitabine
Hivid, Dacogen (tezacitabine) is a small molecule pharmaceutical. Tezacitabine was first approved as Hivid on 1992-06-19. It has been approved in Europe to treat myeloid leukemia.
| Trade Name | Dacogen |
|---|---|
| Common Name | Tezacitabine |
| Indication | myeloid leukemia |
| Drug Class | Nucleoside antiviral or antineoplastic agents, cytarabine or azarabine derivatives |
